AMRI witnessed strong growth in two of its contract business during
the first quarter of 2008 although profit was impacted by its
dominant large-scale division, which lagged during the period.
Parexel has announced healthy financial results for its third
fiscal quarter, despite another disappointing performance in its
medical communications business.
Biotech giant Amgen has posted healthy results for the first
quarter following a positive performance by its blockbuster anaemia
drug Aranesp (darbepoetin alfa).
Cambrex has recorded a gain in the third quarter of this year, with
growth in its Bioproducts and Human Health segments. The company's
troublesome BioPharma division continues to underperform,
indicative of a market for outsourced...
US life science company Serologicals' decision to enter into a
€167.6 million merger with cell signalling specialist Upstate looks
to have been the right one as its third quarter performance
indicates its increasing presence...